Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial
Year: 2023
Type: conference-abstract
Source: Blood
Authors: James M. Foran, Li Chen, Selina M Luger, Zhuoxin Sun, Heidi Klepin, David F. Claxton, Hillard M. Lazarus, Jacob M. Rowe, Jessica K. Altman, Aref Al-Kali, Hong Zheng, Keith W Pratz, Edward R. Broun, Bayard L Powell, Kristen M. O'Dwyer, Yishai Ofran, John E. Godwin, Mark R. Litzow, Martin S. Tallman, Lynne Wagner
Institutions: Mayo Clinic in Florida, Dana-Farber Cancer Institute, Hospital of the University of Pennsylvania, Wake Forest University Health Sciences, Wake Forest University, Penn State Cancer Institute, Case Western Reserve University, Shaare Zedek Medical Center, Bikur Cholim Hospital, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Mayo Clinic, University of Pennsylvania, Wake Forest Baptist Comprehensive Cancer Center, University of Rochester Medicine, Providence Portland Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389247492